Apollomics, Inc. (NASDAQ:APLMW) Sees Significant Increase in Short Interest

Apollomics, Inc. (NASDAQ:APLMW) was the target of a large increase in short interest in January. As of January 15th, there was short interest totalling 18,900 shares, an increase of 2,600.0% from the December 31st total of 700 shares. Based on an average trading volume of 82,200 shares, the days-to-cover ratio is presently 0.2 days.

Apollomics Stock Up 0.9 %

Shares of APLMW traded up $0.00 during trading hours on Thursday, reaching $0.01. 51,054 shares of the stock traded hands, compared to its average volume of 20,444. Apollomics has a 52 week low of $0.01 and a 52 week high of $0.04. The stock has a fifty day simple moving average of $0.01 and a 200 day simple moving average of $0.01.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.